The Evolving Management of Bone Disease:
Changes on the Horizon

Please read through the following information and click the appropriate links.

Release Date: June 10, 2005
Available for Credit Through: (Accreditation Expired)

This CME activity was planned and produced in accordance with the ACCME Essential Areas and Policies.

Physician Accreditation
Medical Education Resources is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

Credit Designation
Medical Education Resources designates this continuing medical education activity for a maximum of 1 category 1 credit toward the AMA’s Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Target Audience
This program is intended for clinical practitioners and clinical investigators involved in the management of metabolic bone disease.
Program Goal
The goal of this program is to offer healthcare professionals the opportunity to review the latest clinical data and approaches in the management of metabolic bone disease.

Learning Objectives
At the conclusion of this program, participants should be able to
  • Identify and assess unmet medical needs in the management of metabolic bone disease
  • Predict the importance of treating patients with hip fracture and determine effects on morbidity and mortality
  • Describe novel uses of bisphosphonates currently under investigation
Program Completion Time
1 hour.

ASBMR Disclaimer
The content for this industry supported CME activity was presented at the ASBMR 26th Annual Meeting and is not a part of the official program of the American Society for Bone and Mineral Research. Medical Education Resources is responsible for the organization and scientific content for this event in accordance with the Essential Areas and Policies of the ACCME as well as the FDA guidelines.

MER Disclaimer
The content and views presented in this educational activity are those of the authors and not necessarily those of Medical Education Resources or Integrated Communications Corp. The authors have disclosed if any unlabeled use of products are mentioned in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted.

This program is supported by an unrestricted educational grant from Novartis Pharmaceuticals Corporation.


Printer settings may vary. Please use landscape layout option.

Copyright © 2005 Scinexa, LLC / CMEdiscovery.com / ArcMesa Educators, LLC. All rights reserved.